Characterization and toxicity of citral incorporated with nanostructured lipid carrier
The nanoparticle as a cancer drug delivery vehicle is rapidly under investigation due to its promising applicability as a novel drug delivery system for anticancer agents. This study describes the development, characterization and toxicity studies of a nanostructured lipid carrier (NLC) system for c...
Main Authors: | Noraini Nordin, Swee Keong Yeap, Nur Rizi Zamberi, Nadiah Abu, Nurul Elyani Mohamad, Heshu Sulaiman Rahman, Chee Wun How, Mas Jaffri Masarudin, Rasedee Abdullah, Noorjahan Banu Alitheen |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2018-01-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/3916.pdf |
Similar Items
-
Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model
by: Noraini Nordin, et al.
Published: (2020-06-01) -
Preparation and Characterization of Self Nano-Emulsifying Drug Delivery System Loaded with Citraland Its Antiproliferative Effect on Colorectal Cells In Vitro
by: Mira Nadiah Mohd Izham, et al.
Published: (2019-07-01) -
In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity
by: Siyamak Ebrahimi Nigjeh, et al.
Published: (2019-09-01) -
Citral induced apoptosis in MDA-MB-231 spheroid cells
by: Siyamak Ebrahimi Nigjeh, et al.
Published: (2018-02-01) -
Negative Impact of Citral on Susceptibility of Pseudomonas aeruginosa to Antibiotics
by: Alexandre Tetard, et al.
Published: (2021-07-01)